Focus Biomolecules will be exhibiting at the Spring 2023 Science, Technology & Career Event presented by the Penn Postdoc Association (PPA) of the University of Pennsylvania. […]
Journal Club: Lisa Pallareti and coworkers at Univ. Copenhagen reported on the pharmacological characterization of agonists and antagonists of the orphan receptor GPR139. GPR139 is predominantly […]
Focus will be exhibiting at AACR, April 16-19 in Orlando, FL. Stop by our booth #3242 and chat with our scientists! Learn about our new cutting-edge […]
A small molecule that binds DNA at one bis-intercalation site can affect binding by another moiety nearby. WP631 is a novel bis-intercalating daunomycin dimer and potent […]
New Product Focus: Chroman 1 is an important new small molecule tool for the generation and maintenance of stem cells. An extremely potent (1 pM) inhibitor […]
Journal Club: Surfactin is a cyclic lipopeptide microbial metabolite produced by Bacillus subtilis that acts as a biosurfactant among other interesting activities. S.C. Yang and coworkers […]
In The News: Bempedoic acid is an FDA-approved drug for the treatment of hypercholesterolemia sold under the brand name Nexletol. It is an ATP citrate lyase […]
Focus on Drug Discovery: Saridegib is a natural product-inspired drug candidate. Its prototype, cyclopamine was discovered as a teratogenic steroidal alkaloid that was found to cause […]
Journal Club: Hutchinson-Gilford progeria syndrome (HGPS) is a rare premature aging disorder caused by the expression of progerin, a Lamin A mutant. The study of HGPS […]
The Focus Biomolecules Website is set to allow the use of cookies. Cookies help us to give you the best experience on our website. By clicking Accept or continuing to use the site, you agree to use our cookies. If you decline we will not track your information but your browsing experience might be limited. For more information on our Privacy Policy click here.APPROVEDECLINE